ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
1
views
0
references
Top references
cited by
4
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
2,756
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Effectiveness of istradefylline for fatigue and quality of life in Parkinson’s disease patients’ and of their caregivers’
Author(s):
K ABE
,
M Fujita
,
H Yoshikawa
,
H YOSHIKAWA
,
Kazuo Abe
,
Masashi Fujita
,
Hiroo Yoshikawa
,
K Abe
Publication date:
2016
Journal:
Adv Parkinson’s Dis
Read this article at
ScienceOpen
Publisher
Further versions
open (via page says license)
oa repository (semantic scholar lookup)
Powered by
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
RNA drug delivery
Author and article information
Journal
DOI::
10.4236/apd.2016.52004
ScienceOpen disciplines:
Medicine
,
Pharmacology & Pharmaceutical medicine
Data availability:
ScienceOpen disciplines:
Medicine
,
Pharmacology & Pharmaceutical medicine
Comments
Comment on this article
Sign in to comment
scite_
Similar content
2,756
Could istradefylline be a treatment option for postural abnormalities in mid-stage Parkinson's disease?
Authors:
Tomoyuki Uchiyama
,
Tomoyuki Miyamoto
,
Keisuke Suzuki
…
Two new adenosine receptor antagonists for the treatment of Parkinson's disease: istradefylline versus tozadenant.
Authors:
Santiago Perez-Lloret
,
Marcelo Merello
Blood hexokinase reduction in de novo Parkinson’s disease and remodeling of glycolytic energy homeostasis with L-DOPA/Istradefylline combination therapy.
Authors:
N Kanzato
,
K. Nakachi
,
S Mochizuki
…
See all similar
Cited by
4
Caffeine and Selective Adenosine Receptor Antagonists as New Therapeutic Tools for the Motivational Symptoms of Depression
Authors:
Laura López-Cruz
,
John D. Salamone
,
Mercè Correa
New Developments on the Adenosine Mechanisms of the Central Effects of Caffeine and Their Implications for Neuropsychiatric Disorders
Authors:
Sergi Ferré
,
Manuel Díaz-Ríos
,
John D. Salamone
…
Istradefylline for OFF Episodes in Parkinson’s Disease: A US Perspective of Common Clinical Scenarios
Authors:
Stuart Isaacson
,
Sagari Bette
,
Rajesh Pahwa
See all cited by